Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05KRX
|
|||
Drug Name |
Quinoline derivative 10
|
|||
Synonyms |
PMID27724045-Compound-13
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Janssen Pharmaceutica
|
|||
Structure |
Download2D MOL |
|||
Formula |
C25H27ClF3N7O2
|
|||
Canonical SMILES |
C1CN(CC1N)C2=NC3=C(C=C2)C(=C(C=C3)Cl)C(=O)NCC(C4=CN=C(N=C4)C(F)(F)F)N5CCOCC5
|
|||
InChI |
1S/C25H27ClF3N7O2/c26-18-2-3-19-17(1-4-21(34-19)36-6-5-16(30)14-36)22(18)23(37)31-13-20(35-7-9-38-10-8-35)15-11-32-24(33-12-15)25(27,28)29/h1-4,11-12,16,20H,5-10,13-14,30H2,(H,31,37)/t16-,20?/m0/s1
|
|||
InChIKey |
WVZNREBVNBJZKF-DJZRFWRSSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | P2X purinoceptor 7 (P2RX7) | Target Info | Antagonist | [1] |
Target's Patent Info | P2X purinoceptor 7 (P2RX7) | Target's Patent Info | [1] | |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Reactome | The NLRP3 inflammasome | |||
WikiPathways | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
References | Top | |||
---|---|---|---|---|
REF 1 | P2X7 receptor antagonists: a patent review (2010-2015).Expert Opin Ther Pat. 2017 Mar;27(3):257-267. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.